CVS Health Corporation
CVS
$63.66
-$3.85-5.70%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | 2.05B | 2.26B | 1.90B | 2.14B | 2.33B |
Total Depreciation and Amortization | 1.13B | 1.13B | 1.10B | 1.00B | 1.04B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 228.00M | 60.00M | 149.00M | 264.00M | 382.00M |
Change in Net Operating Assets | -6.04B | -732.00M | 2.75B | 4.04B | -5.71B |
Cash from Operations | -2.64B | 2.72B | 5.91B | 7.44B | -1.95B |
Capital Expenditure | -911.00M | -545.00M | -591.00M | -984.00M | -688.00M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -120.00M | -18.00M | -9.38B | -7.09B | -8.00M |
Divestitures | -- | -- | -- | -- | 679.00M |
Other Investing Activities | -211.00M | -208.00M | -391.00M | -436.00M | -102.00M |
Cash from Investing | -1.24B | -771.00M | -10.36B | -8.51B | -119.00M |
Total Debt Issued | 200.00M | -1.00B | 10.95B | 5.95B | -- |
Total Debt Repaid | -432.00M | -947.00M | -6.43B | -362.00M | -16.00M |
Issuance of Common Stock | 35.00M | 122.00M | 24.00M | 96.00M | 41.00M |
Repurchase of Common Stock | -5.00M | -4.00M | -132.00M | -2.05B | -1.53B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -779.00M | -779.00M | -795.00M | -779.00M | -719.00M |
Other Financing Activities | 9.00M | -89.00M | 7.00M | -128.00M | 40.00M |
Cash from Financing | -972.00M | -2.70B | 3.63B | 2.73B | -2.19B |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -4.85B | -752.00M | -828.00M | 1.65B | -4.26B |